Efficacy and Safety of Prescribing in Transplantation (ESPRIT) Group, Barts and the London School of Medicine and Dentistry, London by Atholl Johnston.
by Maria Dalby – Transplantation across the immune barrier is becoming increasingly common, but constitutes a risk factor for the development of donor-specific antibodies and thus for long-term… read more.
Maria Dalby reporting from the annual British Transplantation Society meeting in Glasgow by Anthony Dorling, King’s College London – Chronic rejection is a major cause of graft failure… read more.
Maria Dalby reporting on the presentation by Dorry Segev, Johns Hopkins University, Baltimore, USA – Every transplant surgeon has had his/her share of cases that turned out less… read more.
From the annual meeting of the British Transplantation Society in Glasgow by Marc J. Clancy. Since its establishment within the mainstream of clinical care, the technology of organ… read more.
First therapy to target damage after heart attack could transform field. After a heart attack, much of the damage to the heart muscle is caused by inflammatory cells… read more.
Measuring creatine levels with MRI has benefits over contrast-enhanced MRI and MRS. A new MRI method to map creatine at higher resolutions in the heart may help clinicians… read more.
by Bruce Sylvester – Abatacept, an FDA-approved treatment of rheumatoid arthritis could become the first targeted therapy for focal segmental glomerulosclerosis glomerulosclerosis (FSGS), a condition that usually causes… read more.
Bernhard Banas, Regensburg, Germany – Prolonged-release tacrolimus administered once-daily provides high rates of graft survival and reduction in biopsy-confirmed acute rejection (BCAR), with a manageable tolerability profile, in patients… read more.
Re-transplantation is the only option available for salvaging a failed abdominal graft. As the outcomes after primary transplantations continue to improve, even with the increasing use of extended-criteria… read more.
Invasive microbial infections are a major cause of morbidity and mortality in organ transplantation patients. The satellite symposia sponsored by Astellas Pharma at ESOT 2013 discussed the challenge… read more.
by Peter Friend, Oxford, UK – The 16th ESOT Congress in Vienna 2013 was one of ESOT’s most comprehensive arrangements to date, with more than 3,500 attendees and… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
